Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment

被引:46
作者
Anderson, GD
Lin, YX
Berge, C
Ojemann, GA
机构
[1] UNIV WASHINGTON, SCH PHARM, DEPT PHARMACEUT, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, SCH PHARM, DEPT NEUROL SURG, SEATTLE, WA 98195 USA
[3] UNIV WASHINGTON, SCH MED, SEATTLE, WA 98195 USA
关键词
valproate; valproic acid; bleeding; cortical resection;
D O I
10.3171/jns.1997.87.2.0252
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Valproate (VPA) is associated with a variety of idiosyncratic hematological effects including thrombocytopenia, inhibition of platelet aggregation, and fibrinogen depletion. This has led some investigators to recommend discontinuation of VPA therapy prior to elective surgical procedures. However, administration of VPA therapy is not altered prior to surgery at the authors' center and no VPA-associated bleeding complications have been observed. Therefore, a retrospective chart review was conducted to verify the clinical observations in patients who had undergone cortical resection while receiving antiepileptic drugs (AEDs). Baseline, surgical, and postoperative laboratory data were available for a total of 313 patients, 111 of whom were receiving VPA and 202 of whom were receiving AEDs without VPA (control patients). Eighty-seven percent of the patients receiving VPA were also being treated with at least one other AED. The control group was approx imately equally divided between monotherapy (55%) and polytherapy (45%) treatments. Platelet counts were significantly lower in the control polytherapy (284 +/- 74 X 10(9)/L) and both VPA groups (279 +/- 113 X 10(9)/L) as compared with the control monotherapy group (314 +/- 85 X 10(9)/L). Baseline fibrinogen levels were significantly lower in the VPA than in the control groups (223 +/- 91 g/dl vs. 278 +/- 95 g/dl). Both pre- and postoperatively, the VPA group had lower red blood cells counts, hematocrit, and hemoglobin levels. There was no significant difference between groups in estimated blood loss during surgery or qualitative wound discharge postsurgery. There was only one case of a bleeding complication, which occurred 14 days postoperatively in a patient receiving carbamazepine monotherapy. The results of this study confirm the clinical observations of an absence of bleeding complications in patients receiving VPA therapy at the time of surgery, despite differences in laboratory parameters.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 28 条
[1]   VALPROIC ACID AND IMMUNE THROMBOCYTOPENIA [J].
BARR, RD ;
COPELAND, SA ;
STOCKWELL, ML ;
MORRIS, N ;
KELTON, JC .
ARCHIVES OF DISEASE IN CHILDHOOD, 1982, 57 (09) :681-684
[2]  
CHENG RD, 1989, ANN NEUROL, V26, P457
[3]  
COULTER D L, 1980, Journal of the American Medical Association, V244, P785, DOI 10.1001/jama.244.8.785
[4]  
GANICK DJ, 1990, AM J PEDIAT HEMATOL, V12, P80
[5]   VALPROATE-MEDIATED DISTURBANCES OF HEMOSTASIS - RELATIONSHIP TO DOSE AND PLASMA-CONCENTRATION [J].
GIDAL, B ;
SPENCER, N ;
MALY, M ;
PITTERLE, M ;
WILLIAMS, E ;
COLLINS, M ;
JONES, J .
NEUROLOGY, 1994, 44 (08) :1418-1422
[6]  
HOFFMAN LM, 1982, CAN MED ASSOC J, V126, P358
[7]   NEUTROPENIA DURING SODIUM VALPROATE TREATMENT [J].
JAEKEN, J ;
VANGOETHEM, C ;
CASAER, P ;
DEVLIEGER, H ;
EGGERMONT, E ;
PILET, M .
ARCHIVES OF DISEASE IN CHILDHOOD, 1979, 54 (12) :986-987
[8]   SODIUM VALPROATE IN TREATMENT OF EPILEPSY [J].
JEAVONS, PM ;
CLARK, JE .
BRITISH MEDICAL JOURNAL, 1974, 2 (5919) :584-586
[9]   VALPROIC-ACID-INDUCED PANCYTOPENIA AND COOMBS-TEST POSITIVITY [J].
KAYA, IS ;
DILMEN, U ;
TOPPARE, M ;
SENSES, DA ;
PRENTICE, HG .
LANCET, 1991, 337 (8751) :1227-1228
[10]   BONE-MARROW SUPPRESSION INDUCED BY HIGH-DOSE VALPROIC ACID [J].
KISHI, T ;
FUJITA, N ;
KAWAGUCHI, H ;
ISHIMAE, M ;
WATANABE, K ;
TANAKA, T .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 71 (02) :153-155